Marketing In Biotech: Crafting The Message That Moves Science Forward

A survey of biotech investors found that 86% believe that fewer than half of management teams communicate effectively, ...
STAT

Crisis in CRISPR world, RFK Jr.’s promises, and a novel non-opioid pain drug

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Adam Feuerstein is a ...
STAT

Uncertainty in CRISPR world and the start of more M&A

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
Wired

The World’s First Crispr Drug Gets a Slow Start

Deshawn “DJ” Chow waited a year to receive a treatment that could change his life. The 19-year-old was born with sickle cell disease, which makes his red blood cells crescent-shaped and sticky. The ...
MedCity News

CRISPR Biotech Caribou Trims Pipeline and Cuts 32% of Staff to Focus on Two Cancer Cell Therapies

Caribou Biosciences’ 2025 outlook aimed for key trial readouts for two cancer cell therapies in the first half of the year and the start of clinical testing in an autoimmune disease. The CRISPR ...